Category: news & events

Clearance Recognises Celldx-Tissue’s Dual-Analyte DNA and RNA Workflow Across 517 Cancer-Associated Genes, with ALK, RET and ROS1 Fusion Calls on RNA-Level Evidence Datar Cancer Genetics (DCG), a global precision oncology company, today announced that its tissue-based comprehensive genomic profiling (CGP) assay for all solid tumors, Celldx-Tissue, has been cleared by the US Food and Drug… Continue reading Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA

We are proud that 15 of our abstracts have been accepted for the ASCO Annual Meeting 2026, including both online publications and on-site poster presentations. Our research projects address current challenges in modern oncology — ranging from molecular diagnostics and multi-omics analyses to innovative approaches for personalised therapies. We are especially looking forward to presenting… Continue reading Strong Presence at ASCO 2026: 15 Accepted Abstracts

This year, we will once again be present at the ESMO Congress. Following our successful participation in recent years, we are especially looking forward to Berlin. The congress will take place from 17–21 October 2025. Visit us at our booth and take the opportunity to exchange ideas with us on the latest developments in oncology.… Continue reading Join us at ESMO 2025 in Berlin

Following last year’s successful participation, we will once again be present with a booth at this year’s ESMO. This year’s congress will take place from September 13th – 17th in Barcelona. We look forward to welcoming you at our booth and discussing the latest developments in oncology with you! More information on our abstract submissions… Continue reading ESMO 2024 in Barcelona

We are delighted to announce that Dr Timothy Crook, Consultant Medical Oncologist at Cromwell Hospital, is presenting alongside international colleagues at the European Society for Medical Oncology (ESMO) in October. The ESMO is the leading European society for oncological education and information, with more than 30,000 members – oncology experts from 168 countries worldwide. The… Continue reading ESMO 2023 – Dr. Crook presents together with Datar Cancer Genetics

The US Food and Drug Administration (FDA) has now also granted our blood test for the diagnosis of CNS tumours a “Breakthrough Device Designation”. Following our blood tests for the early detection of prostate and breast cancer, this is the third test to receive this designation from the FDA. If tumours are considered inoperable or… Continue reading Further Breakthrough Device Designation from the FDA – now also for blood test to diagnose inaccessible brain tumours

We are pleased to announce that Dr Massimo Cristofanilli, Dr Razelle Kurzrock as well as Prof Sendurai Mani have agreed to join our Scientific Advisory Board. Dr. Massimo Cristofanilli will chair the Scientific Advisory Board in the future. Dr Cristofanilli is an internationally recognised physician, researcher and ambitious scientist. Among other things, he has developed… Continue reading RENOWNED ASSIGNMENT TO THE SCIENTIFIC ADVISORY BOARD OF DATAR CANCER GENETICS

Distinguishing patients with intracranial malignancies from those with benign diseases is difficult, as the symptoms are often non-specific. This study investigates whether the detection of glial malignancies based on the enrichment and identification of circulating glial cells (CGCs) in peripheral blood is an effective strategy for the rapid and simple diagnostic stratification of such patients.… Continue reading PROMISING INITIAL STUDY RESULTS IN THE DETECTION OF GLIAL MALIGNANCIES USING GLIAL CELLS IN THE BLOOD

The case study shows that cancer patients with rare tumour entities can benefit from a broader molecular-genetic tumour profile. This is important for cancer patients for whom empirical therapies are ineffective and potential therapies are being researched based on tumour-specific profiles and taking into account possible resistance mechanisms. The publication was produced in collaboration with… Continue reading HOT NEWS! OUR LATEST PUBLICATION IN FRONTIERS IN MEDICINE